Attorney Matt Zorn is suing the Drug Enforcement Administration (DEA) for failing to release records related to its communications with Smart Approaches to Marijuana (SAM), an anti-cannabis group.
This lawsuit, filed November 28, seeks to compel the DEA to produce these records under the Freedom of Information Act (FOIA), reported Marijuana Moment.
The request came just days before hearings on cannabis rescheduling got underway on December 2 at DEA headquarters in Arlington, Virginia.
Zorn argues that the DEA broke public records laws by not responding to his FOIA request made on October 29.
The law requires agencies to reply within 20 days, excluding weekends.
The lawsuit follows a recent decision by an administrative law judge who denied the DEA's motion to remove itself from the rescheduling hearings. The judge noted serious concerns about the DEA's contact with SAM, which could affect the fairness of the process.
SAM has long fought against marijuana legalization and reform. Its involvement in the rescheduling talks has raised alarms among pro-reform groups. Critics say the DEA's communication with SAM could unfairly influence the hearing’s outcome.
Read Also: Veterans Group Challenges DEA For Seat At Cannabis Debate Table
Another Wrinkle In The Process
In response to a separate motion, the DEA denied allegations of improper communication with SAM, dismissing them as “gossip” and arguing that any contact was not unlawful, despite SAM’s president Kevin Sabet’s admission of discussing rescheduling details with DEA insiders. SAM also denied that the conversations had to do with the rescheduling procedure.
The DEA held its first hearing on Monday to lay the groundwork for discussing the Biden administration’s proposal to reclassify marijuana. The next steps include witness testimonies presented by approved participants.
The move could lead to major changes in cannabis regulation, including tax benefits and expanded research opportunities, though stopping short of full legalization.
Cover: AI generated image
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.